Fulgent Genetics, Inc. (FLGT) Misses Q3 EPS by 11c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q3 EPS of $0.06, $0.11 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $105.66 million versus the consensus estimate of $103.7 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• UBS Reiterates Buy Rating on Darden Restaurants (DRI) Ahead of Q1 Earnings
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print